A Comparative Study of Serological and Stool Antigen Tests for Helicobacter pylori Infection Diagnosis in Northern Iraq
Shier Ali Khorsheed 1*
Journal of Angiotherapy 8(4) 1-9 https://doi.org/10.25163/angiotherapy.849578
Submitted: 05 March 2024 Revised: 03 April 2024 Published: 06 April 2024
Abstract
Background: Helicobacter pylori infection is prevalent worldwide and linked to gastrointestinal disorders, including gastritis, ulcers, and stomach cancer. Accurate diagnosis is crucial for effective treatment and monitoring. Non-invasive tests like serology and stool antigen testing are commonly used for diagnosis, but their comparative efficacy needs evaluation, especially in regions with varying prevalence rates. Methods: This comparative study included 120 participants from northern Iraq, comprising 60 with gastrointestinal disorders (mainly dyspepsia) and 60 healthy controls. Stool and serum samples were collected, and stool antigen tests and serological analysis (IgM) were performed. Results: The prevalence of H. pylori infection was higher in patients than controls, with 41.7% positive for stool antigen tests compared to 28.3% in controls (p = 0.003), and 37.5% positive for serology compared to 25.8% in controls (p = 0.001). Stool antigen testing demonstrated higher sensitivity in detecting active infection. Discussion: Non-invasive diagnostic methods like stool antigen tests offer advantages such as ease of implementation and unaffectedness by medications. In this study, stool antigen testing showed superior efficacy in detecting active H. pylori infection compared to serology, which may retain antibodies post-treatment, potentially leading to false positives. Conclusion: Both serological and stool antigen tests are valuable for diagnosing H. pylori infection, with stool antigen testing exhibiting higher sensitivity, especially in identifying active infections. The study recommends the use of stool antigen tests, particularly in dyspepsia patients, to determine active infection before initiating treatment, considering its superiority over serology. However, factors like sample handling and environmental conditions may affect stool antigen test results.
Keywords: Helicobacter pylori, Serology, Stool antigen test, Gastrointestinal disorders, Diagnosis.
References
Awuku, Y. A., Simpong, D. L., Alhassan, I. K., Tuoyire, D. A., Afaa, T., & Adu, P. (2017) .Prevalence of Helicobacter pylori infection among children living in a rural setting in Sub-Saharan Africa. BMC Public Healt; 17, 1-6.
Bagirova, M., Allahverdiyev, A. M., Abamor, E. S., Aliyeva, H., Unal, G., & Tanalp, T. D.(2017). An overview of challenges to eradication of Helicobacter pylori infection and future prospects. Eur Rev Med Pharmacol Sci: 21(9), 2199-2219.
Best LM, Takwoingi Y, Siddique S, Selladurai A, Gandhi A, Low B, Yaghoobi M, Gurusamy KS.(2018). Non-invasive diagnostic tests for Helicobacter pylori iinfection. Cochrane Database of Systematic Reviews 15; 3(3).
Bordin, D. S., Voynovan, I. N., Andreev, D. N., & Maev, I. V. (2021) .Current Helicobacter pylori diagnostics: 11(8), 1458.
Cano-Contreras, A. D., Rascon, O., Amieva-Balmori, M., Rios-Galvez, S., Maza, Y. J., Meixueiro-Daza, A., & Remes-Troche, J. M. (2018). Approach, attitudes, and knowledge of general practitioners in relation to Helicobacter pylori are inadequate. There is much room for improvement. Revista De Gastroenterología De México; 83(1), 16-24.
Crowe SE.(2019). Helicobacter pylori infection. New England Journal of Medicine. Mar 21; 380(12):1158-65.
Diagnosis of Helicobacter pylori Infection. Helicobacter 17, 1-8.
Garza-González, E., Perez-Perez, G. I., Maldonado-Garza, H. J., & Bosques-Padilla, F. J.(2014). A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. WJG: Feb 20(6), 1438..
Huh CW, Kim BW. (2018). Diagnosis of Helicobacter pylori infection. The Korean Journal of Gastroenterology: 72(5):229-36.
Hussein, R. A., Al-Ouqaili, M. T., & Majeed, Y. H. (2021). Detection of Helicobacter Pylori infection by invasive and non-invasive techniques in patients with gastrointestinal diseases from Iraq: A validation study. Plos one, 16 (8).
Iannone, A., Giorgio, F., Russo, F., Riezzo, G., Girardi, B., Pricci, M. ... & Ierardi, E.(2018). New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study. World journal of gastroenterology, 24(27), 3021.
Ishaq S, Nunn L.(2015). Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterology and hepatology from bed to bench. 8 (l1): S .6.
Jiménez, G. (2018). Helicobacter pylori Como patogeno emergente en el ser humano. Revista Costarricense de Salud Pública: 27(1), 65-78.
Karkhah, A., Ebrahimpour, S., Rostamtabar, M., Koppolu, V., Darvish, S., Vasigala, V. K. R, & Nouri, H. R. (2019). Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases. Microbiological research 218, 49-57.
Koletzko, L., Macke, L., Schulz, C., & Malfertheiner, P. (2019). ). Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit. Best Practice & Researc Clinical Gastroenterology; 40 101637.
Lee YC, Dore MP, Graham DY.(2022). Diagnosis and treatment of Helicobacter pylori infection. Annu Rev Med Jan 1; 73:4-1.
Miftahussurur, M.(2020). Noninvasive Helicobacter pylori diagnostic methods in Indonesia. Gut and Liver: 14(5), 553. doi: 10.5009/gnl19264.
Moss, S. F. (2017) .The clinical evidence linking Helicobacter pylori to gastric cancer. Cellular and molecular gastroenterology and hepatology: 3(2), 183-191..
Negash M, Kassu A, Amare B, Yismaw G, Moges B.(2018). Evaluation of SD BIOLINE H. pylori Ag rapid test against double ELISA with SD. H. pylori Ag ELISA and EZ-STEP H. pylori Ag ELISA tests. BMC Clinical Pathology. Dec; 18(1):1-6.
Pylori Tonkic, A., Tonkic, M., Lehours, P., & Mégraud, F. (2012) .Epidemiology and
Qiu E, Li Z, Han S. (2021).Methods for detection of Helicobacter pylori from stool sample: current options and developments. Brazilian Journal of Microbiology. Dec 52(4):2057-62.
Rostami, H., & Haddadi, M. H., (2022) Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori-related diseases. Fundamental & Clinical Pharmacology; 36(6), 930-943.
Sabbagh P, Mohammadnia-Afrouzi M, Javanian M, Babazadeh A, Koppolu V, Vasigala VR, Nouri HR, Ebrahimpour S.(2019). Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. European Journal of Clinical Microbiology & Infectious Diseases 38(1):55-66.
Stefano, K., Marco, M., Federica, G., Laura, B., Barbara, B., Gioacchino, L., & Gian, L. D. A. (2018). Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Bio Medica: Atenei Parmensi; 89 (8), 72.
Suzuki N, Wakasugi M, Nakaya S, et al.(2002). Production and application of new monoclonal antibodies specific for a fecal Helicobacter pylori antigen. Clin Diagn Lab Immunol 9:75–8.
Tanaka A, Watanabe K, Tokunaga K, et al. (2003).Evaluation of Helicobacter pylori stool antigen test before and after eradication therapy. J Gastroenterol Hepatol 2003;18:732–8
Tonkic A, Vukovic J, Vrebalov Cindro P, Pesutic Pisac V, Tonkic M.(2018). Diagnosis of Helicobacter pylori infection. Wiener klinische Wochenschrift. Sep; 130(17):530-4.
Wang, Y. K., Kuo, F. C., Liu, C. J., Wu, M. C., Shih, H. Y., Wang, S. S., ... & Wu, D. C. (2015) .Diagnosis of Helicobacter pylori infection: Current options and developments. WJG: 21(40), 11221.
Waskito, L. A., & Yamaoka, Y.(2019) The story of Helicobacter pylor: depicting human migrations from the phylogeography. Helicobacter pyloriin Human Diseases: Advances in Microbiology, Infectious Diseases and Public Healt, (11) 1-16.
Yadav, A. K., Verma, D., Chaudhary, N., Kumar, A., & Solanki, P. R. (2022). Aptamer based switches: A futuristic approach for Helicobacter pylori detection. Materials Letter; 308, 131239.
View Dimensions
View Altmetric
Save
Citation
View
Share